Skip to content

Effect of exercise training on sarcopenia in elderlies

The effects of TRX Suspension Training on sarcopenic neuromuscular markers and functional abilities in elderlies with sarcopenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230727058944N1
Enrollment
30
Registered
2023-09-20
Start date
2020-07-22
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

With aging, there is an inevitable progressive loss of muscle mass and strength called sarcopenia that is associated with the risk of impairment in physical ability which could lead to consequences such as falls, fall-related injuries, hospitalizations, and even mortality.. Muscle wasting and atrophy, not elsewhere classified

Interventions

Intervention 1: Intervention group: TRX training group: Participants were trained for 8 weeks, three sessions per week, and about 60 min per session. Intervention 2: Control group: Participants in the

Sponsors

Allameh Tabataba'i University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Age more than 65 years Handgrip strength lower than 32Kg SMM/height2 lower than 9.2 kg/m2 Being sedentary for at least 1 year (didn’t have more than 1h exercise per week)

Exclusion criteria

Exclusion criteria: Cardiovascular or pulmonary diseases, diabetes, Joint and muscle problems, and Mental and cognitive disorders Involvement in any extra exercise training programs Not interested to continue or change in personal life schedule

Design outcomes

Primary

MeasureTime frame
Myostatin levels. Timepoint: 24 hours before intervention and 48 hours after intervention. Method of measurement: Collection of venous blood samples with a syringe and laboratory assessments.;Follistatin levels. Timepoint: 24 hours before intervention and 48 hours after intervention. Method of measurement: Collection of venous blood samples with a syringe and laboratory assessments.;GDF-15 levels. Timepoint: 24 hours before intervention and 48 hours after intervention. Method of measurement: Collection of venous blood samples with a syringe and laboratory assessments.;CAF levels. Timepoint: 24 hours before intervention and 48 hours after intervention. Method of measurement: Collection of venous blood samples with a syringe and laboratory assessments.

Secondary

MeasureTime frame
Handgrip strength. Timepoint: 24 hours before intervention and 48 hours after intervention. Method of measurement: Jamar hand dynamometer (USA) with five handle positions and the second position was used for all participants.;Gait speed. Timepoint: 24 hours before intervention and 48 hours after intervention. Method of measurement: Walking speed of participants was assessed using a stopwatch.;Time Up and Go (TUG). Timepoint: 24 hours before intervention and 48 hours after intervention. Method of measurement: TUG test was assessed using a stopwatch.;Chair stand speed. Timepoint: 24 hours before intervention and 48 hours after intervention. Method of measurement: chair stand test was assessed using a stopwatch.;Standing balance. Timepoint: 24 hours before intervention and 48 hours after intervention. Method of measurement: The standing balance test was assessed using a stopwatch.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRasoul Eslami

Allameh Tabataba'i University

eslami.rasul@gmail.com+98 918 366 4507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026